| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |